Westpac Banking Corp Purchases New Position in Intuitive Surgical, Inc. $ISRG

Westpac Banking Corp acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,979 shares of the medical equipment provider’s stock, valued at approximately $1,211,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its holdings in shares of Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $1,335,753,000. Amundi grew its position in Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. increased its stake in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock valued at $769,948,000 after purchasing an additional 184,044 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 2.0%

Shares of NASDAQ:ISRG opened at $399.06 on Friday. The stock’s fifty day simple moving average is $423.51 and its two-hundred day simple moving average is $427.91. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The stock has a market cap of $138.33 billion, a PE ratio of 48.25, a price-to-earnings-growth ratio of 3.02 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.40 EPS. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a report on Wednesday, October 21st. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Wednesday, October 21st. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price on the stock. in a report on Thursday, July 30th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Thursday, November 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $495.90.

Check Out Our Latest Analysis on Intuitive Surgical

Intuitive Surgical News Roundup

Investors following ISRG have been watching these news items:

  • Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
  • Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
  • Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 1,078 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the sale, the vice president owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,363 shares of company stock valued at $17,738,749 over the last three months. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

See Also

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.